OP 6.3 – 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia

• G. Webb,
• H. Wu,
• C. Waytashek,
• C. Boyle,
• J. Smedley,
• J. Zikos,
• D. Magnani,
• S. Fuchs,
• R. Desrosiers,
• J. Sacha

Affiliations

G. Webb

Oregon Health And Science University, Beaverton, USA

H. Wu

Oregon Health And Science University, Beaverton, USA

C. Waytashek

Oregon Health And Science University, Beaverton, USA

C. Boyle

Oregon Health And Science University, Beaverton, USA

J. Smedley

Oregon National Primate Research Center, Beaverton, USA

J. Zikos

Massbiologics, Boston, USA

D. Magnani

Massbiologics, Boston, USA

S. Fuchs

University of Miami, Miami, USA

R. Desrosiers

University of Miami, Miami, USA

J. Sacha

Oregon Health And Science University, Beaverton, USA